Expertise in
2
conditions

Guillaume Louvel

Villejuif, FR 
Expertise in
2
conditions
Villejuif, FR 

Overview

Guillaume Louvel practices practicing medicine in Villejuif, France.

Mr. Louvel is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Glioma, Gliomatosis Cerebri, Ganglioglioma, and Lymphocytic Vasculitis.

He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Villejuif, France
Other Locations
114 Rue Edouard Vaillant 94805 Villejuif, Rouez, 94805, France
Orsay, France
Paris, 75005, France
Avenue De La Bataille Flandre Dunkerque, Rennes, 35000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: July 01, 2025
Intervention Type: Drug, Radiation
Study Drugs: Marizomib, Temozolomide
Study Phase: Phase 3
Hypofractionated Stereotactic Radiation Treatments (SBRT) on Children, Teenagers and Young Adults Malignant Tumors
Hypofractionated Stereotactic Radiation Treatments (SBRT) on Children, Teenagers and Young Adults Malignant Tumors
Enrollment Status: Completed
Publish Date: March 08, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
View 1 Less Clinical Trial

39 Total Publications

ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer.
ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer.
Journal: Annales d'endocrinologie
Published: April 22, 2025

Frequently Asked Questions about Guillaume Louvel

Is Guillaume Louvel a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Guillaume Louvel is classified as an Advanced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Guillaume Louvel participate in research or clinical trials?

Yes. Guillaume Louvel has published 39 articles and abstracts on conditions like Glioma. You can view a list of Guillaume Louvel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Louvel's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile